Lv1
98 积分 2024-10-15 加入
A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer
2个月前
已完结
A single-cell and spatially resolved atlas of human breast cancers
2个月前
已完结
Hippo/YAP signaling choreographs the tumor immune microenvironment to promote triple negative breast cancer progression via TAZ/IL-34 axis
3个月前
已完结
The role of ECM mechanics in cancer mechanotransduction through unraveling the molecular machinery of integrins, FAK, and YAP signaling
3个月前
已完结
Activation of Wnt/β-catenin signaling promotes immune evasion via the β-catenin/IKZF1/CCL5 axis in hepatocellular carcinoma
9个月前
已完结
YAP/TAZ as master regulators in cancer: modulation, function and therapeutic approaches
11个月前
已完结
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
1年前
已完结
Lenvatinib non-inferior to sorafenib for hepatocellular carcinoma
1年前
已完结
Contrasting cytotoxic and regulatory T cell responses underlying distinct clinical outcomes to anti-PD-1 plus lenvatinib therapy in cancer
1年前
已完结
皖公网安备34019202002308
